Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 20/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

60%

6 trials in Phase 3/4

Results Transparency

83%

5 of 6 completed trials have results

Key Signals

2 recruiting5 with results

Enrollment Performance

Analytics

Phase 3
6(60.0%)
Phase 2
3(30.0%)
N/A
1(10.0%)
10Total
Phase 3(6)
Phase 2(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)